Artiva Biotherapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-venBio Global Strategic Fund III, L.P.(6.3%),venBio Global Strategic GP III, L.P.(6.3%)等
Artiva Biotherapeutics | 10-Q:季度报表
Artiva Biotherapeutics | 8-K:Artiva Biotherapeutics公布2024年第三季度财务业绩和近期业务亮点
Artiva Biotherapeutics | 4:持股变动声明-董事 MOORE ALISON
Artiva Biotherapeutics | 3:首次持股声明-董事 MOORE ALISON
Artiva Biotherapeutics | 8-K:重大事件
Artiva Biotherapeutics | 4:持股变动声明-高管 Raymon Heather
Artiva Biotherapeutics | 4:持股变动声明-高管 Graef Thorsten
Artiva Biotherapeutics | 4:持股变动声明-高管 Horan Christopher
Artiva Biotherapeutics | 4:持股变动声明-高管 Bush Jennifer
Artiva Biotherapeutics | 4:持股变动声明-高管 Krishnamohan Neha
Artiva Biotherapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(40.6%),Peter Kolchinsky(40.6%)等
Artiva Biotherapeutics | 10-Q:季度报表
Artiva Biotherapeutics | 8-K:Artiva Biotherapeutics公布2024年第二季度财务业绩和近期业务亮点
Artiva Biotherapeutics | SC 13G:超过5%持股股东披露文件-venBio Global Strategic Fund III, L.P.(7.8%),venBio Global Strategic GP III, L.P.(7.8%)等
Artiva Biotherapeutics | SC 13G:超过5%持股股东披露文件-Andrew J. Schwab(10.1%),Kush Parmar(10.1%)等
Artiva Biotherapeutics | SC 13G:超过5%持股股东披露文件-Venrock Healthcare Capital Partners III, L.P.(6.9%),VHCP Co-Investment Holdings III, LLC(6.9%)等
Artiva Biotherapeutics | SC 13D:超过5%持股股东披露文件-RA Capital Management, L.P.(42.3%),Peter Kolchinsky(42.3%)等
Artiva Biotherapeutics | SC 13D:超过5%持股股东披露文件-GC Corp.(19.6%),Yong-Jun Huh(19.6%)等
Artiva Biotherapeutics | 4:持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.